FDA approves Seattle firm's cancer drug Provenge
Apr 29, 2010 1:50:08 PM - komonews.com
The Food and Drug Administration says it has approved a drug developed by a Seattle company that is designed to stimulate a patient's immune system to fight prostate cancer. Shares of Dendreon Corp. jumped to new highs on the news.
USA, Washington: (Latest Stories)